Biotech · Private company · Emeryville, CA, US
Topaz Biosciences, Inc.
Track this companyFree. Adds Topaz Biosciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Development of novel endolysins targeting Cutibacterium acnes to treat acne vulgarisFiscal year 2026 · $576.5KNIH RePORTER 5R44AR082722-03 · fetched Nov 12, 2026
- Development of novel endolysins targeting Cutibacterium acnes to treat acne vulgarisFiscal year 2025 · $1.5MNIH RePORTER 2R44AR082722-02A1 · fetched Nov 12, 2026
- Metagenomic discovery and optimization of novel endolysins targeting Gardnerella vaginalis to treat bacterial vaginosisFiscal year 2024 · $300KNIH RePORTER 1R43AI186717-01 · fetched Nov 12, 2026